User profiles for Rodolphe Thiébaut
 | Rodolphe ThiébautUniversité de bordeaux Verified email at u-bordeaux.fr Cited by 25949 |
[HTML][HTML] Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment
…, T Croughs, S Beq, R Thiébaut… - The Journal of …, 2009 - Am Soc Clin Investig
HIV infection results in CD4 + T cell deficiency, but efficient combination antiretroviral
therapy (c-ART) restores T cells and decreases morbidity and mortality. However, immune …
therapy (c-ART) restores T cells and decreases morbidity and mortality. However, immune …
[HTML][HTML] Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination
…, H Bonnabau, R Thiebaut… - The Journal of …, 2019 - Am Soc Clin Investig
BACKGROUND. Systems vaccinology allows cutting-edge analysis of innate biomarkers of
vaccine efficacy. We explored a strategy to shape the adaptive immune response by …
vaccine efficacy. We explored a strategy to shape the adaptive immune response by …
Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data
R Thiébaut, S Leproust, G Chêne, R Gilbert - The Lancet, 2007 - hal.science
BACKGROUND: Despite three decades of prenatal screening for congenital toxoplasmosis
in some European countries, uncertainty remains about the effectiveness of prenatal …
in some European countries, uncertainty remains about the effectiveness of prenatal …
Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study
N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk… - Aids, 2003 - journals.lww.com
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among
HIV-infected persons, and to investigate any association between such risk factors, stage …
HIV-infected persons, and to investigate any association between such risk factors, stage …
Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination
…, V Jojic, CL Dekker, R Thiébaut… - Proceedings of the …, 2014 - National Acad Sciences
Females have generally more robust immune responses than males for reasons that are not
well-understood. Here we used a systems analysis to investigate these differences by …
well-understood. Here we used a systems analysis to investigate these differences by …
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …
Background The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss… - European journal of …, 2010 - academic.oup.com
Aims HIV-infected patients receiving combination antiretroviral therapy may experience
metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs). …
metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs). …
Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need …
Background. Recent updates of human immunodeficiency virus (HIV) treatment guidelines
have raised the CD4+ cell count thresholds for antiretroviral therapy initiation from 350 to 500 …
have raised the CD4+ cell count thresholds for antiretroviral therapy initiation from 350 to 500 …
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
…, J Larmarange, E Balestre, R Thiebaut… - The lancet HIV, 2018 - thelancet.com
Background Universal antiretroviral therapy (ART), as per the 2015 WHO recommendations,
might reduce population HIV incidence. We investigated the effect of universal test and treat …
might reduce population HIV incidence. We investigated the effect of universal test and treat …
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis
…, M Balduin, MR Jakobsen, AM Geretti, R Thiebaut… - Jama, 2011 - jamanetwork.com
Context Presence of low-frequency, or minority, human immunodeficiency virus type 1 (HIV-1)
drug resistance mutations may adversely affect response to antiretroviral treatment (ART), …
drug resistance mutations may adversely affect response to antiretroviral treatment (ART), …